Concepts of extracellular matrix remodelling in tumour progression and metastasis

被引:1233
|
作者
Winkler, Juliane [1 ]
Abisoye-Ogunniyan, Abisola [1 ]
Metcalf, Kevin J. [1 ]
Werb, Zena [1 ]
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Anat, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
CANCER-ASSOCIATED FIBROBLASTS; MAMMARY-GLAND INVOLUTION; CROSS-LINK SWITCH; BREAST-CANCER; BONE-MARROW; GENE-EXPRESSION; CELL-MIGRATION; LYSYL OXIDASE; TENASCIN-C; TISSUE TRANSGLUTAMINASE;
D O I
10.1038/s41467-020-18794-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tissues are dynamically shaped by bidirectional communication between resident cells and the extracellular matrix (ECM) through cell-matrix interactions and ECM remodelling. Tumours leverage ECM remodelling to create a microenvironment that promotes tumourigenesis and metastasis. In this review, we focus on how tumour and tumour-associated stromal cells deposit, biochemically and biophysically modify, and degrade tumour-associated ECM. These tumour-driven changes support tumour growth, increase migration of tumour cells, and remodel the ECM in distant organs to allow for metastatic progression. A better understanding of the underlying mechanisms of tumourigenic ECM remodelling is crucial for developing therapeutic treatments for patients. Tumors are more than cancer cells - the extracellular matrix is a protein structure that organizes all tissues and is altered in cancer. Here, the authors review recent progress in understanding how the cancer cells and tumor-associated stroma cells remodel the extracellular matrix to drive tumor growth and metastasis.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease
    Rabelink, Ton J.
    van den Berg, Bernard M.
    Garsen, Marjolein
    Wang, Ganqi
    Elkin, Michael
    van der Vlag, Johan
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (04) : 201 - 212
  • [42] A multiphase model of tumour segregation in situ by a heterogeneous extracellular matrix
    Arduino, A.
    Preziosi, L.
    INTERNATIONAL JOURNAL OF NON-LINEAR MECHANICS, 2015, 75 : 22 - 30
  • [43] RB constrains lineage fidelity and multiple stages of tumour progression and metastasis
    Walter, David M.
    Yates, Travis J.
    Ruiz-Torres, Miguel
    Kim-Kiselak, Caroline
    Gudiel, A. Andrea
    Deshpande, Charuhas
    Wang, Walter Z.
    Cicchini, Michelle
    Stokes, Kate L.
    Tobias, John W.
    Buza, Elizabeth
    Feldser, David M.
    NATURE, 2019, 569 (7756) : 423 - +
  • [44] From transformation to metastasis: deconstructing the extracellular matrix in breast cancer
    Shelly Kaushik
    Michael W Pickup
    Valerie M Weaver
    Cancer and Metastasis Reviews, 2016, 35 : 655 - 667
  • [45] Extracellular Matrix Alterations in Metastatic Processes
    Paolillo, Mayra
    Schinelli, Sergio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [46] The extracellular matrix as a multitasking player in disease
    Theocharis, Achilleas D.
    Manou, Dimitra
    Karamanos, Nikos K.
    FEBS JOURNAL, 2019, 286 (15) : 2830 - 2869
  • [47] Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling
    Gutowski, NJ
    Newcombe, J
    Cuzner, ML
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1999, 25 (03) : 207 - 214
  • [48] Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis
    Conlon, Guy A.
    Murray, Graeme I.
    JOURNAL OF PATHOLOGY, 2019, 247 (05): : 629 - 640
  • [49] Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis
    Brown, Gordon T.
    Murray, Graeme I.
    JOURNAL OF PATHOLOGY, 2015, 237 (03): : 273 - 281
  • [50] Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
    Brassart-Pasco, Sylvie
    Brezillon, Stephane
    Brassart, Bertrand
    Ramont, Laurent
    Oudart, Jean-Baptiste
    Monboisse, Jean Claude
    FRONTIERS IN ONCOLOGY, 2020, 10